Douglas Fambrough, President and CEO at Dicerna Pharmaceuticals Inc (DRNA), bought 5,000 shares at $22.10 ($111K) on 2021-08-10, disclosed to the SEC on 2021-08-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| DRNA | BUY | 2016-11-16 | $123K | — | Filing → |
| DRNA | BUY | 2014-02-20 | $75K | — | Filing → |